XWRAP customers have provided anecdotal evidence suggesting that XWRAP outperforms other skin substitutes currently available in the market. This superiority stems from its unique processing, dehydration, and sterilization methods. The proprietary processing of XWRAP has demonstrated superior handling and biodegradability characteristics. It exhibits a slower and more controlled breakdown, thereby offering prolonged and enhanced performance as a protective cover and wound barrier. The product undergoes natural dehydration without heat and a gentle sterilization process, which helps preserve its durability and extracellular matrix.
In contrast, similar products not subjected to such sterilization tend to rapidly degrade, resulting in inferior performance compared to XWRAP. XWRAP has been selected for its exceptional performance attributes, expected to reduce product usage and enhance patient outcomes. Ongoing clinical studies on XWRAP are currently underway, with results anticipated for publication by the end of the year.
